← Scroll for more →
Financial Statements — BABA
Balance Sheet
(in billions CNY)| Metric | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 131.53 | 145.49 | 34.37 | 193.09 | 189.90 | 321.26 | 46.68 | 189.98 |
| Short-term Investments | 155.31 | -- | -- | -- | -- | -- | -- | -- |
| Accounts Receivable | 36.02 | 31.17 | 30.69 | 32.13 | 32.81 | 27.08 | 19.79 | 13.77 |
| Total Current Assets | 88.54 | 92.89 | 104.27 | 697.97 | 100.73 | 98.20 | 65.38 | 40.27 |
| Property, Plant & Equipment | 40.98 | 203.35 | 185.16 | 176.03 | 171.81 | 22.50 | 103.39 | 13.71 |
| Goodwill | 35.86 | 255.50 | 35.97 | 268.09 | 42.53 | 292.77 | 276.78 | 264.94 |
| Intangible Assets | 16.98 | 2.88 | 3.73 | 6.83 | 9.34 | 10.81 | 8.61 | 68.28 |
| Total Non-current Assets* | 1,821.03 | 1,711.34 | 1,660.56 | 1,055.08 | 1,594.83 | 1,592.02 | 120.05 | 103.53 |
| Total Assets | 1,909.57 | 1,804.23 | 1,764.83 | 1,753.04 | 1,695.55 | 1,690.22 | 185.43 | 143.80 |
| Accounts Payable | 52.17 | 45.83 | 297.88 | 275.95 | 271.46 | 260.93 | 161.54 | 17.54 |
| Short-term Debt | -- | -- | -- | -- | -- | -- | -- | 7.36 |
| Total Current Liabilities | 69.06 | 435.35 | 421.51 | 385.35 | 60.54 | 377.36 | 34.16 | 207.67 |
| Total Non-current Liabilities* | 44.49 | 278.77 | 230.72 | 244.77 | 552.82 | 229.23 | 399.18 | (155.56) |
| Total Liabilities | 113.56 | 714.12 | 652.23 | 630.12 | 613.36 | 606.58 | 433.33 | 52.10 |
| Total Stockholder Equity | 1,060.89 | 1,009.86 | 136.64 | 144.10 | 948.48 | 937.47 | 755.40 | 73.35 |
← Scroll for more columns →
* Derived from reported values
Income Statement
(in billions CNY) (except per-share rows)| Metric | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 1,023.67 | 996.35 | 941.17 | 126.49 | 853.06 | 717.29 | 509.71 | 56.15 |
| Cost of Revenue | 616.14 | 598.29 | 586.32 | 80.04 | 539.45 | 421.21 | 282.37 | 206.93 |
| Gross Profit | 407.53 | 398.06 | 49.15 | 318.99 | 49.47 | 45.19 | 227.34 | 169.92 |
| Research & Development | 66.53 | 57.15 | 52.26 | 56.74 | 55.47 | 57.24 | 43.08 | 37.44 |
| Selling, General & Admin | 4.80 | 44.24 | 41.99 | 6.14 | 5.04 | 8.43 | 28.20 | 3.71 |
| Total Operating Expenses | 357.38 | 257.16 | 33.45 | 218.64 | 38.49 | 31.50 | 135.91 | 16.81 |
| Operating Income | 7.27 | 140.91 | 15.70 | 14.61 | 10.99 | 89.68 | 91.43 | 57.08 |
| Interest Expense | 9.79 | 1.32 | 7.95 | 5.92 | 4.91 | 4.48 | 5.18 | 0.77 |
| Pretax Income | 18.76 | 155.46 | 14.07 | 12.99 | 59.55 | 165.58 | 166.65 | 96.22 |
| Tax Provision | 4.36 | 35.45 | 22.53 | 15.55 | 26.82 | 29.28 | 20.56 | 16.55 |
| Net Income | 15.02 | 130.11 | 80.01 | 72.78 | 62.25 | 22.98 | 149.43 | 87.89 |
| Basic EPS | 0.83 | 0.95 | 3.95 | 0.50 | 0.45 | 1.06 | 1.00 | 0.63 |
| Diluted EPS | 5.50 | 6.70 | 0.54 | 3.43 | 0.45 | 1.04 | 6.99 | 4.17 |
← Scroll for more columns →
Cash Flow Statement
(in billions CNY)| Metric | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | 76.21 | 163.51 | 182.59 | 199.75 | 142.76 | 231.79 | 180.61 | 22.50 |
| Capital Expenditures | -- | -- | -- | -- | -- | -- | 24.66 | 32.34 |
| Free Cash Flow* | -- | -- | -- | -- | -- | -- | 155.95 | (9.84) |
| Investing Cash Flow | (67.34) | (25.55) | (3.02) | (135.51) | (31.33) | (244.19) | (108.07) | (22.51) |
| Financing Cash Flow | (2.98) | (10.50) | (108.24) | (65.62) | (10.17) | 4.59 | 70.85 | (1.10) |
← Scroll for more columns →
* Derived from reported values